Thermo Fisher coronavirus diagnostic test gets FDA’s emergency use order
Thermo Fisher Scientific has been granted an emergency use authorization (EUA) for its coronavirus diagnostic test from the US Food and Drug Administration (FDA). The ... Read More
Rapid coronavirus test developed by Chicago-based Surgisphere
Rapid coronavirus test : Chicago-based Surgisphere Corporation claims to have launched a rapid diagnostic tool for novel coronavirus. The healthcare data analytics and medical education ... Read More
F2G’s olorofim gets FDA ODD for mold infections and Valley Fever
F2G has bagged orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for olorofim (formerly F901318) for the treatments of invasive mold ... Read More
FDA approves Opdivo + Yervoy for HCC previously treated with sorafenib
Bristol Myers Squibb has secured approval for the combination of Opdivo (nivolumab) 1 mg/kg and Yervoy (ipilimumab) 3 mg/kg from the US Food and Drug ... Read More
VisCardia wraps up VisONE heart failure pilot study
VisONE heart failure pilot study : Oregon-based medical device developer VisCardia has wrapped up its first-in-human study of the implantable VisONE system for medically refractory ... Read More
Coronavirus testing center in New York : Northwell Labs begins manual testing for COVID-19
Coronavirus testing center in New York : New York health care provider Northwell Health Labs (Northwell Labs) has started manual testing of novel coronavirus samples ... Read More
COVID-19 treatment : Cyclica, Institute of Materia Medica partner on drug repurposing for coronavirus
COVID-19 treatment : The Institute of Materia Medica, Chinese Academy of Medical Sciences has entered into a collaboration with Canadian biotech company Cyclica for discovering ... Read More
Gilead Sciences to acquire immuno-oncology company Forty Seven for $4.9bn
Gilead Sciences acquisition of Forty Seven : US biotech company Gilead Sciences has signed an all-cash deal worth around $4.9 billion to acquire Forty Seven, ... Read More
Antibe Therapeutics completes patient enrollment in OA knee pain trial for ATB-346
Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical trial of its lead drug candidate ATB-346 ... Read More
Cerovene bags FDA approval for Daraprim generic for toxoplasmosis treatment
Cerovene has bagged approval from the US Food and Drug Administration (FDA) for its generic version of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis ... Read More